Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 ...

A new analysis of clinical trial data indicates that psilocybin, when administered alongside psychotherapy, may provide rapid ...

A new study shows that natural mushroom extracts may be more therapeutically effective than synthesized psilocybin, which is widely used in research investigating the medicinal potential of the ...

A new study published in the Journal of Psychopharmacology found that serotonergic antidepressants like SSRIs and SNRIs can decrease psilocybin’s effects, Psychedelic Spotlight reports. Serotonergic ...

Many people with tough-to-treat depression may be trying psilocybin, the active ingredient in magic mushrooms, as an alternative to antidepressants. Thinking that it's a "natural" drug, folks might ...

On Tuesday, November 12th, students at the University of Wisconsin received an email from the Raison Lab asking if they were interested in a lab studying the effect of psilocybin. The study offered up ...

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical ...

Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional ...